Natural Capsules Intrinsic Value
Natural Capsules (NATCAPSUQ) median intrinsic value is ₹366.75 from 4 valuation models (range ₹80–₹371), vs current price ₹148.56 — +146.9% upside (Trading Below Calculated Value), margin of safety 59.5%. Read NATCAPSUQ dividend history for the complete payout history and dividend yield track record.
NATCAPSUQ Valuation Methods Summary — DCF, Graham Number & P/E
Natural Capsules intrinsic value across 4 models vs current price ₹148.56 — upside/downside and value range per method. For current market price and key ratios, visit Natural Capsules share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹371.40 | ₹334.26 - ₹408.54 | +150.0% | Book Value/Share: ₹222.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹297.12 | ₹267.41 - ₹326.83 | +100.0% | Revenue/Share: ₹236.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹80.00 | ₹72.00 - ₹88.00 | -46.1% | EBITDA: ₹8.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹366.75 | ₹293.40 - ₹440.10 | +146.9% | CF Growth: 15.0%, Discount: 15% |
NATCAPSUQ Intrinsic Value vs Market Price — All Valuation Models
Natural Capsules fair value range ₹80–₹371 vs current market price ₹148.56 across 4 valuation models. Analyse NATCAPSUQ shareholder distribution to track promoter, FII and institutional holdings.
NATCAPSUQ Intrinsic Value Analysis — Undervalued or Overvalued?
Natural Capsules median intrinsic value ₹366.75, current price ₹148.56 — Trading Below Calculated Value by 146.9%, margin of safety 59.5%.
What is the intrinsic value of NATCAPSUQ?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Natural Capsules (NATCAPSUQ) is ₹366.75 (median value). With the current market price of ₹148.56, this represents a +146.9% variance from our estimated fair value.
The valuation range spans from ₹80.00 to ₹371.40, indicating ₹80.00 - ₹371.40.
Is NATCAPSUQ undervalued or overvalued?
Based on our multi-method analysis, Natural Capsules (NATCAPSUQ) appears to be trading below calculated value by approximately 146.9%.
NATCAPSUQ Financial Health — Key Ratios vs Industry Benchmarks
Natural Capsules financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -9.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.56x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
NATCAPSUQ Cash Flow Quality — Operating & Free Cash Flow
Natural Capsules operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹27 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-8 Cr | ₹-45 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹17 Cr | ₹-36 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹-1 Cr | ₹-24 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹13 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |